Evidence map›Paper›PMID 41347883›Full record

ReviewChemical record (New York, N.Y.)2026

Benzochromanone and Benzochromene Natural Products: Synthetic Strategies and Total Syntheses.

Takuya Kumamoto

Abstract readReview
In one paragraph

Review in Chemical record (New York, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Takuya KumamotoDepartment of Synthetic Organic Chemistry, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.ORCID 0000-0003-1973-1551

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This account overviews our synthetic strategies for natural products featuring benzochromanone and benzochromene frameworks. The total synthesis of monomeric benzochromanones, particularly xanthones and benzochromanones is achieved. Key accomplishments include the development of a versatile synthetic approach for constructing xanthone frameworks via spirochromanone intermediates and the successful total syntheses of (±)-4-deoxyblennolide C, (+)-blennolide C, and chromanone lactone gonytolide C. The asymmetric total synthesis of benzochromene (R)-(+)-teretifolione B and the first asymmetric synthesis of (R)-(+)-methylteretifolione B are also achieved. The Diels-Alder reaction between benzyne derived from chromene precursors and oxygenated furans enabled efficient access to benzochromene derivatives. The enantioselective synthesis of teretifolione B and related compound was accomplished through the enzymatic resolution of racemic chromenes, and the reaction conditions were investigated to improve regioselectivity in key steps. These synthetic routes provide access to a diverse array of benzochromanone and benzochromene derivatives with potential biological activity.

Indexed as

BenzopyransBiological ProductsChromonesCycloaddition ReactionMolecular StructureStereoisomerismBenzopyransBiological ProductsChromonesbenzochromenesDiels‐Alder reactionspiro compoundstotal synthesisxanthones

Identifiers

PMID41347883
PMCPMC12933010

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.